Jensen Thomas
Transaction: 01/28/2026
BUY
Change
+200,000
Price
Not reported
Filing
05/14/2026
Type
BUY
Allarity Therapeutics, Inc.
ALLR • Biotechnology
$1.42
▼ -0.01 (-0.70%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$22.59M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.14Healthy liquidity · 2.13Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 23, 2026, 12:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.42
Change-0.70%
Shares Out15.91M
Market Cap$22.59M
Enterprise Value$5.61M
52W Range0.77 - 2.35
Beta0.51
P/E-1.83
P/S65.49
P/B6.39
P/FCF-1.64
EV/Sales16.26
Price$1.42
Change-0.70%
Shares Out15.91M
Market Cap$22.59M
Enterprise Value$5.61M
52W Range0.77 - 2.35
Beta0.51
P/E-1.83
P/S65.49
P/B6.39
P/FCF-1.64
EV/Sales16.26
EV/EBITDA-0.50
EV/FCF-0.41
Earnings Yield-54.59%
FCF Yield-60.97%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-39.39%
Profit Margin-35.10%
Debt/Eq0.14
Current Ratio2.13
Quick Ratio2.13
Volume111.23K
Avg Volume159.41K
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
55/100
Why this score▼
Manageable debt level · 0.14Healthy liquidity · 2.13Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
75/100
Bullish
Bullish
1
Hold
1
Bearish
0
Insider Transactions
Recent executive and insider activity
Hoeiland Jesper
Transaction: 01/07/2026
BUY
Change
+25,000
Price
Not reported
Filing
05/11/2026
Type
BUY
Hoeiland Jesper
Transaction: 06/10/2025
OTHER
Change
0
Price
Not reported
Filing
05/11/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Jensen Thomas | BUY | +200,000 | Not reported | 01/28/2026 | 05/14/2026 |
| Hoeiland Jesper | BUY | +25,000 | Not reported | 01/07/2026 | 05/11/2026 |
| Hoeiland Jesper | OTHER | 0 | Not reported | 06/10/2025 | 05/11/2026 |
| McLaughlin Gerald W. | BUY | +45,000 | Not reported | 01/28/2026 | 05/07/2026 |
| Ervin Jeffrey S | BUY | +150,000 | Not reported | 01/28/2026 | 04/30/2026 |
| Graff Jeremy R. | BUY | +133,333 | Not reported | 01/28/2026 | 04/30/2026 |
| Graff Jeremy R. | BUY | +133,333 | Not reported | 01/07/2026 | 01/16/2026 |
| Graff Jeremy R. | SELL | -14,613 | $1.58 | 09/30/2025 | 10/02/2025 |
| Graff Jeremy R. | SELL | -39,494 | Not reported | 09/30/2025 | 10/02/2025 |
| Ervin Jeffrey S | OTHER | 0 | Not reported | 07/01/2025 | 07/14/2025 |
| Benjamin Laura | BUY | +25,000 | $1.01 | 01/22/2025 | 01/24/2025 |
| Vazzano Joseph Walter | BUY | +25,000 | $1.01 | 01/22/2025 | 01/24/2025 |
| McLaughlin Gerald W. | BUY | +25,000 | $1.01 | 01/22/2025 | 01/24/2025 |
| Jensen Thomas | BUY | +396,734 | Not reported | 01/22/2025 | 01/24/2025 |
| Epshinsky Alexander | BUY | +29,496 | Not reported | 01/22/2025 | 01/24/2025 |
| Graff Jeremy R. | BUY | +144,441 | Not reported | 01/22/2025 | 01/24/2025 |
| Graff Jeremy R. | OTHER | 0 | Not reported | 09/30/2024 | 10/01/2024 |
| Graff Jeremy R. | BUY | +118,483 | $2.11 | 09/30/2024 | 10/01/2024 |
| Epshinsky Alexander | SELL | 0 | Not reported | 09/12/2024 | 09/18/2024 |
| Benjamin Laura | OTHER | 0 | Not reported | 08/01/2023 | 08/28/2023 |